Quarterly report (Form 10-Q)
Johnson & Johnson 10-Q for Quarter ended Jun 28, 2026
Filing excerpt
In October 2025, the Company announced its intention to separate its Orthopaedics business. The Company continues to explore multiple paths to effect the planned separation with a targeted completion within 18 to 24 months after the initial announcement.